These results indicated that hUC-MSCs controlled the levels of insulin tolerance and serum insulin in T2DM mice by affecting the expression of signaling factors in the PI3K/Akt signaling pathway. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.